Checkmate Pharmaceuticals Inc (CMPI) Return on Investment ROI from the first quarter of 2022 to first quarter of 2021 and for the year 2022, average high and low, overall ranking from Mar 31 2022 to Mar 31 2021 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Checkmate Pharmaceuticals Inc   (NASDAQ: CMPI)


Checkmate Pharmaceuticals Inc's ROI from its first quarter of 2022 to the first quarter of 2021 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Checkmate Pharmaceuticals Inc's ROI in the first quarter of 2022?
Checkmate Pharmaceuticals Inc recorded a cumulative net loss of $-63 million during 12 months ending in the first quarter of 2022, resulting in a negative return on investment (ROI) of -83.92%.

Within the Healthcare sector 936 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Mar 31 2022 quarter, so far to 5194, from total ROI ranking in the fourth quarter of 2021 at 5321.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter
Y / Y Investment Change TTM 51.34 % 316.85 % -22.48 % 186.17 % -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 55 69 82 95 112
Return On Investment (TTM) -83.92 % -68.54 % -144.15 % -99.11 % -87.83 %
CMPI's Overall Ranking # 5194 # 5321 # 4723 # 4846 # 3593
Seq. Investment Change TTM -16.02 % 118.91 % -24.69 % 9.31 % 131.33 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -63 -61 -59 -54 -44

CMPI Company Profile >> Back to CMPI Roi Comparisons >> See Annual CMPI Return On Investment



Return On Investment CMPI's Ranking
Within: No.
Industry # 147
Sector # 937
Overall # 5194

Return On Investment Statistics
High Average Low
-12.58 %
-75.7 %
-144.15 %
(Mar 31 2021)   (Sep 30 2021)







Financial Statements
Checkmate Pharmaceuticals Inc's I. Quarter Investments $ 55 Millions CMPI's Balance sheet
Checkmate Pharmaceuticals Inc's I. Quarter Income $ -16 Millions Quarterly CMPI's Income Statement
CMPI's Income by Division See CMPI's Income by Division


CMPI Annual Return On Investment (Dec 31 2021)
2021		 (Dec 31 2020)
2020


Total Investments in Millions 69 125 0 0 0
Y / Y Investment Growth -44.52 % - - - -
Net Income in Millions -61 -37 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -88.4 % -29.85 % - - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CMPI's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CMPI's Competitors
Subscribers only: Roi for Checkmate Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for CMPI's Customers

Other Ratios
CMPI's Roa CMPI's Inventory Turnover Ratio CMPI's Growth Rates CMPI's Dividend Statistics
CMPI's Profitability Ratios CMPI's Asset Turnover Ratio CMPI's Dividend Growth
CMPI's Roe CMPI's Valuation Ratios CMPI's Financial Strength Ratios CMPI's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2022, within Healthcare Sector ROI

Date modified: 2026-10-07T00:41:47+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.